HRI sponsoring 2022 Cardiovascular Postgraduate Scholarship
HRI is sponsoring a new Cardiovascular Postgraduate Scholarship under the Sydney Research Awards and Scholarships program.
One step closer to understanding atherosclerosis
Dr Ashish Misra published a review that brings us one step closer to understanding the inner workings of atherosclerosis, the major cause of stroke and heart attack.
Link between dementia and atrial fibrillation (irregular heartbeat)
A major new report, led by HRI's Prof Ben Freedman, has confirmed a strong link between atrial fibrillation (irregular heartbeat) and dementia.
Prof Roland Stocker awarded 2021 Basic Science Award
Professor Roland Stocker, leader of the Arterial Inflammation and Redox Biology Group at HRI, has been awarded the 2021 Basic Science Award from the esteemed Society for Free Radical Research-Europe.
New hope for babies born with heart defect
Dr Ashish Misra is conducting research that opens a pathway towards a improved therapy for patients with the heart defect SVAS.
First congenital heart disease registry launched in Australia
In an Australian first, doctors have developed the Australian New Zealand Congenital Heart Disease Registry to help improve the lives of people living with the condition, and their families.
Six significant grants to solve the UK’s biggest killer – cardiovascular disease
HRI is delighted to announce the award of six grants funded by HRI UK donors to support research into cardiovascular disease – the world’s biggest killer.
A pioneering generation: people with complex congenital heart disease living longer
People born with half a heart or single-ventricle congenital heart disease (Fontan-CHD) are now living longer than ever before, thanks to advances in medicine and technology.
Arterial Inflammation and Redox Biology Group publishes in Nature Communications
The Arterial Inflammation and Redox Biology Group, led by Professor Roland Stocker, has published a paper in the prestigious Nature Communications journal.